BK-0086

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameBK-0086
Drug Alias Namepegylated glucagon like peptide-1 mutant (Bio-ker)pegylated GLP-1 mutant (Bio-ker)BK-0086
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBio-Ker Srl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBio-Ker Srl
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A